Memorial Sloan-Kettering Cancer Center in New York recently announced the following appointments:
Chief of Lymphoma
Anas Younes, MD, has been named Chief of the Lymphoma Service in the Division of Hematologic Oncology, Department of Medicine. An internationally recognized medical oncologist with more than 2 decades of experience treating and managing people with lymphoma, Dr. Younes’s research efforts were instrumental in the development of brentuximab vedotin (Adcetris), the first targeted drug approved by the U.S. Food and Drug Administration for the treatment of patients with Hodgkin lymphoma in more than 3 decades.
As Chief of Memorial Sloan-Kettering’s Lymphoma Service, Dr. Younes is responsible for continuing to accelerate the translation of scientific discoveries into novel treatment strategies to improve the cure rate and survival of patients with Hodgkin and non-Hodgkin lymphoma.
Before joining Memorial Sloan-Kettering this year, Dr. Younes served as Director of Clinical Investigation and Translational Research in the Department of Lymphoma/Melanoma at The University of Texas M. D. Anderson Cancer Center, in Houston.
Chief of Pathology
David S. Klimstra, MD, has been appointed Chair of the Department of Pathology and incumbent of the James Ewing Alumni Chair of Pathology. Dr. Klimstra is a surgical pathologist who is highly regarded for his expertise in the surgical pathology of tumors of the pancreas, gastrointestinal tract, liver, lung, salivary glands, and neuroendocrine organs. He has more than 20 years of diagnostic experience in tumor pathology at Memorial Sloan-Kettering.
Chief of Colorectal Service
Julio Garcia-Aguilar, MD, PhD, has been named Chief of the Colorectal Service in the Department of Surgery and incumbent of the Stuart H. Q. Quan Chair. Dr. Garcia-Aguilar has dedicated his career to the surgical care of people with colon and rectal cancer and is an expert in minimally invasive laparoscopic and robotic techniques. His research focuses on improving the quality of life of patients with rectal cancer.
Chief of Molecular Imaging and Therapy
Wolfgang Weber, MD, has joined Memorial Sloan-Kettering as Chief of the Molecular Imaging and Therapy Service in the Department of Radiology and Director of the Laurent and Alberta Gerschel Positron Emission Tomography Center.
Dr. Weber received his medical education, training, and advanced degrees at the Technical University of Munich, in Germany. In 2003 he joined the Department of Molecular and Medical Pharmacology at the University of California. In 2007, he returned to Germany as Chairman of Nuclear Medicine at the University of Freiburg. ■
